196 related articles for article (PubMed ID: 26906191)
1. Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
Abidi MZ; Ledeboer N; Banerjee A; Hari P
Diagn Microbiol Infect Dis; 2016 May; 85(1):116-20. PubMed ID: 26906191
[TBL] [Abstract][Full Text] [Related]
2. Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.
Ramanan P; Barreto JN; Osmon DR; Tosh PK
J Clin Microbiol; 2014 Sep; 52(9):3184-9. PubMed ID: 24951810
[TBL] [Abstract][Full Text] [Related]
3. Invasive Rothia infections in children with acute myeloid leukemia: A report from the Canadian infections in AML research group.
Wang JY; Brossard J; Cellot S; Dix D; Feusner J; Johnston DL; Lewis V; Mitchell D; Portwine C; Price V; Sung L; Ethier MC; Gillmeister B
Pediatr Hematol Oncol; 2016 Aug; 33(5):277-281. PubMed ID: 27315594
[TBL] [Abstract][Full Text] [Related]
4. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
5. Significant morbidity and mortality attributable to rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation.
Chavan RS; Pannaraj PS; Luna RA; Szabo S; Adesina A; Versalovic J; Krance RA; Kennedy-Nasser AA
Pediatr Hematol Oncol; 2013 Aug; 30(5):445-54. PubMed ID: 23659597
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
7. [Bacteremia due to Rothia mucilaginosa after chemotherapy for myeloid malignancies].
Kohashi S; Mori T; Koda Y; Kikuchi T; Kato J; Shimizu T; Sugita K; Hasegawa N; Murata M; Okamoto S
Rinsho Ketsueki; 2015 Jun; 56(6):687-91. PubMed ID: 26256880
[TBL] [Abstract][Full Text] [Related]
8. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
9. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
[TBL] [Abstract][Full Text] [Related]
10. Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.
Poyer F; Friesenbichler W; Hutter C; Pichler H; Dworzak M; Peters C; Mann G; Indra A; Attarbaschi A
Pediatr Blood Cancer; 2019 Jul; 66(7):e27691. PubMed ID: 30825249
[TBL] [Abstract][Full Text] [Related]
11. Blood culture isolates in hemodialysis vascular catheter-related bacteremia.
Alexandraki I; Sullivan R; Zaiden R; Bailey C; McCarter Y; Khan A; Offutt JK; Bhatt UY; Plott D; Nahman NS
Am J Med Sci; 2008 Oct; 336(4):297-302. PubMed ID: 18854670
[TBL] [Abstract][Full Text] [Related]
12. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
13. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
Mrázová-Studená M; Drgona L; Spánik S; Krúpová I; Baláz M; Pichna P; Koren P; Sufliarsky J; Mardiak J; Kunová A; Trupl J; Krcméry V
Neoplasma; 1997; 44(5):314-8. PubMed ID: 9473792
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute.
Fanourgiakis P; Georgala A; Vekemans M; Daneau D; Heymans C; Aoun M
Clin Microbiol Infect; 2003 Oct; 9(10):1068-72. PubMed ID: 14616756
[TBL] [Abstract][Full Text] [Related]
16. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
Sinkó J; Cser V; Konkoly Thege M; Masszi T
Orv Hetil; 2011 Jul; 152(27):1063-7. PubMed ID: 21676672
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
18. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Henwick S; Koehler M; Patrick CC
Clin Infect Dis; 1993 Oct; 17(4):667-71. PubMed ID: 8268348
[TBL] [Abstract][Full Text] [Related]
19. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
[TBL] [Abstract][Full Text] [Related]
20. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
